2-Deoxy-D-glucose operates as a structural antimetabolite of D-glucose. It possesses the capability to disrupt the biosynthesis of pathogen-specific glycoproteins, thereby impeding the cellular replication and proliferation of herpes simplex viruses, lipid-enveloped RNA and DNA viral strains, alongside malignant neoplastic cells.
At present, therapeutic agents and pharmaceutical formulations derived from 2-deoxy-D-glucose have been successfully implemented within clinical protocols addressing herpes simplex infections and oncological disorders. Furthermore, specialized healthcare formulations and anti-aging cosmetic preparations incorporating this biochemical reagent have gained commercial distribution.
Characterized by a favorable safety profile marked by low systemic toxicity and an absence of pronounced adverse reactions, 2-deoxy-D-glucose remains widely adopted across advanced medical therapeutics, anti-aging dermatological products, and fundamental life science investigations, maintaining robust commercial viability and promising developmental horizons.
2-Deoxy-D-glucose Chemical Properties
| Melting point | 146-147 °C(lit.) |
| Alpha | 45.5 º (c=2, H2O) |
| Boiling point | 211.61°C (rough estimate) |
| Density | 1.1738 (rough estimate) |
| Refractive index | 46.5 ° (C=1, H2O) |
| Storage temp | 2-8°C |
| Solubility | H2O: 50 mg/mL, clear, colorless to faintly yellow |
| Form | crystalline |
| Pka | pK1:12.52 (25°C) |
| Color | white |
| Water Solubility | Soluble in water. |
| Merck | 142904 |
| BRN | 1723331 |
| Stability | Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20° for up to 1 month. Solutions in water are not stable and must be used within 1 working day. |
| InChIKey | PMMURAAUARKVCB-CEZCPVKQSA-N |
| LogP | -1.460 (est) |
| CAS DataBase Reference | 154-17-6(CAS DataBase Reference) |
| EPA Substance Registry System | D-arabino-Hexose, 2-deoxy- (154-17-6) |
| Hazard Codes | Xn,Xi |
| Risk Statements | 20/21/22-36/37/38 |
| Safety Statements | 24/25-37/39-36-26 |
| WGK Germany | 3 |
| RTECS | MQ3325000 |
| F | 46091 |
| TSCA | Yes |
| HS Code | 29400090 |
| Hazardous Substances Data | 154-17-6(Hazardous Substances Data) |

Product Application of 2-Deoxy-D-Glucose CAS# 154-17-6:
2-Deoxy-D-glucose operates as a structural derivative of D-glucose, functioning as an active cellular antimetabolite. It serves as a significant biochemical entity interacting with the glycoprotein envelope architecture of diverse viral pathogens, encompassing orthomyxoviruses, paramyxoviruses, and herpesviruses. This specialized compound disrupts the biosynthesis of virus-specific glycoproteins, successfully suppressing the replication and proliferation cycles of herpes simplex viruses, lipid-enveloped RNA and DNA viral strains, as well as malignant breast cancer cellular lines.
Therapeutic agents and pharmaceutical formulations derived from 2-deoxy-D-glucose have undergone active clinical investigation for managing herpes simplex infections, influenza outbreaks, acquired immunodeficiency syndrome (AIDS), and various oncological malignancies. Concurrently, specialized healthcare supplements and advanced anti-aging cosmetic preparations incorporating this biochemical compound have achieved commercial availability in global markets.
Driven by its expanding utility across targeted antiviral therapy, oncological research, and anti-aging dermatological products, 2-deoxy-D-glucose maintains extensive developmental horizons and robust commercial market demand.
